Search Result "Ipilimumab"
Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 61-66
Author(s): Marko Lens, Alessandro Testori, Pier Francesco Ferucci
Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 105-113
Author(s): Marko Lens, Pier F. Ferrucci, Alessandro Testori
Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 8 Year: 2013 Page: 879-894
Author(s): Ana Burgeiro,Faustino Mollinedo,Paulo J. Oliveira
Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy
Journal: Current Cancer Therapy Reviews
Volume: 16 Issue: 1 Year: 2020 Page: 78-85
Author(s): Jason Liu,Cong Xu,Junjia Zhu,Jeffrey Sivik,Joseph J. Drabick,Heath B. Mackley
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 81-86
Author(s): Marlana Orloff, Ryan Weight, Matias E. Valsecchi, Takami Sato
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 9 Year: 2010 Page: 661-665
Author(s): Fanny Julia, Luc Thomas, Charles Dumontet, Stephane Dalle
Improving the Effect of FDA-Mandated Drug Safety Alerts with Internet- Based Continuing Medical Education
Journal: Current Drug Safety
Volume: 8 Issue: 1 Year: 2013 Page: 11-16
Author(s): Carl N. Kraus, Alan T. Baldwin, R.G. McAllister
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 461-467
Author(s): F. Ranchon,A. Boespflug,C. Rioufol,V. Schwiertz,L. Thomas,S. Dalle
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors inClinical Practice in the Volga-Ural Region of the Eurasian Continent
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3312-3323
Author(s): Radmir R. Rakhimov,Aleksandr V. Sultanbaev,Adel A. Izmailov,Konstantin V. Menshikov,Vadim M. Zabelin,Albert A. Izmailov,Gulshat R. Gilyazova,Svetlana M. Izmailova,Ksenia S. Bakhtiyarova,Irina R. Gilyazova,Angelina A. Izmailova
Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma
Journal: Clinical Cancer Drugs
Volume: 2 Issue: 1 Year: 2015 Page: 38-43
Author(s): Maximo de la Vega,Matias E. Valsecchi,Martin Greco,Gonzalo Recondo,Gonzalo Recondo,Enrique Diaz Canton